93382-47-9

Basic information

• Product Name: L-Idopyranuronic acid, 3-O-(phenylmethyl)-, methyl ester, triacetate
• Synonyms: L-Idopyranuronic acid, 3-O-(phenylmethyl)-, methyl ester, triacetate
• CAS NO: 93382-47-9
• Molecular Formula: C₂₀H₂₄O₁₀
• Molecular Weight: 424.4
• Mol File: 93382-47-9.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: L-Idopyranuronic acid, 3-O-(phenylmethyl)-, methyl ester, triacetate(CAS DataBase Reference)
• NIST Chemistry Reference: L-Idopyranuronic acid, 3-O-(phenylmethyl)-, methyl ester, triacetate(93382-47-9)
• EPA Substance Registry System: L-Idopyranuronic acid, 3-O-(phenylmethyl)-, methyl ester, triacetate(93382-47-9)

Safety Data

• Hazardous Substances Data: 93382-47-9(Hazardous Substances Data)

Upstream product

• 108-24-7 acetic anhydride 
• 735326-85-9 (2R,3S,4S,5R)-3,5,6-Triacetoxy-4-benzyloxy-tetrahydro-pyran-2-carboxylic acid 
• 74-88-4 methyl iodide 
• 87326-72-5 3-O-benzyl-1,2-O-isopropyridene-α-D-glucofuranuronic acid 
• 87326-74-7 (S)-((3aR,5S,6S,6aR)-6-Benzyloxy-2,2-dimethyl-tetrahydro-furo[2,3-d][1,3]dioxol-5-yl)-trifluoromethanesulfonyloxy-acetic acid methyl ester 
• 87326-77-0 methyl 3-O-benzyl-L-idopyranosyluronate 
• 75-36-5 acetyl chloride 
• 87326-73-6 (S)-methyl 2-((3aR,5R,6S,6aR)-6-(benzyloxy)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)-2-hydroxyacetate 
• 262382-48-9 1,2,4-tri-O-acetyl-3-O-benzyl-6,7-dideoxy-α,β-L-ido-hepta-6-eno-pyranose 
• 262382-50-3 Acetic acid (3R,4S,5S,6R)-2,5-diacetoxy-4-benzyloxy-6-formyl-tetrahydro-pyran-3-yl ester 
• 106221-09-4 (S)-1-((3aR,5R,6S,6aR)-6-Benzyloxy-2,2-dimethyl-tetrahydro-furo[2,3-d][1,3]dioxol-5-yl)-prop-2-en-1-ol 
• 262382-45-6 tris(thiophenyl) 3-O-benzyl-1,2-O-isopropylidene-β-L-orthoidofuranuronate 
• 582-52-5 1,2:5,6-di-O-isopropylidene-α-D-glucofuranose 
• 87326-76-9 methyl 3-O-benzyl-1,2-O-isopropylidene-α-L-idofuranosiduronate 

Downstream Products

• 628281-01-6 allyl (methyl 3-O-benzyl-α-L-idopyranosyluronate)-(1->4)-O-2-azido-3-O-benzyl-2-deoxy-α-D-glucopyranoside 
• 628281-03-8 allyl (methyl 2-O-acetyl-3-O-benzyl-α-L-idopyranosyluronate)-(1->4)-O-6-O-acetyl-2-azido-3-O-benzyl-2-deoxy-α-D-glucopyranoside 
• 628281-02-7 allyl (methyl 3-O-benzyl-α-L-idopyranosyluronate)-(1->4)-O-2-azido-3,6-di-O-benzyl-2-deoxy-α-D-glucopyranoside 
• 628280-99-9 allyl (methyl 2,4-di-O-acetyl-3-O-benzyl-α-L-idopyranosyluronate)-(1->4)-O-6-O-acetyl-2-azido-3-O-benzyl-2-deoxy-α-D-glucopyranoside 
• 628281-04-9 allyl (methyl 2-O-acetyl-3-O-benzyl-α-L-idopyranosyluronate)-(1->4)-O-2-azido-3,6-di-O-benzyl-2-deoxy-α-D-glucopyranoside 
• 628281-00-5 allyl (methyl 2,4-di-O-acetyl-3-O-benzyl-α-L-idopyranosyluronate)-(1->4)-O-2-azido-3,6-di-O-benzyl-2-deoxy-α-D-glucopyranoside 
• 87907-08-2 C₁₈H₂₁BrO₈ 
• 87907-09-3 methyl 3-O-benzyl-4-O-monochloroacetyl-β-L-idopyranuronate 1,2-(tert-butyl orthoacetate) 
• 92955-26-5 methyl 2-O-acetyl-1,5-anhydro-3-O-benzyl-4-O-chloroacetyl-xylo-hex-1-enitoluronate 
• 87326-99-6 methyl (benzyl 2-O-acetyl-3-O-benzyl-α-L-idopyranosid)uronate 
• 87907-11-7 benzyl 6-O-acetyl-3-O-benzyl-2-<(benzyloxycarbonyl)amino>-2-deoxy-4-O-(methyl 2-O-acetyl-3-O-benzyl-α-L-idopyranosyluronate)-α-D-glucopyranoside 
• 87907-39-9 benzyl O-(3,6-di-O-acetyl-2-azido-4-O-benzyl-2-deoxy-α-D-glucopyranosyl)-(1->4)-O-(methyl 2-O-acetyl-3-O-benzyl-α-L-idopyranosyluronate)-(1->4)-6-O-acetyl-3-O-benzyl-2-(benzyloxycarbonyl)amino-2-deoxy-α-D-glucopyranoside 
• 87907-40-2 benzyl O-(2-azido-4-O-benzyl-2-deoxy-α-D-glucopyranosyl)-(1->4)-O-(methyl 3-O-benzyl-α-L-idopyranosyluronate)-(1->4)-3-O-benzyl-2-(benzyloxycarbonyl)amino-2-deoxy-α-D-glucopyranoside 

Relevant articles and documents

PROCESS FOR PREPARING HEPARINOIDS AND INTERMEDIATES USEFUL IN THE SYNTHESIS THEREOF

Processes are disclosed for the synthesis of the Factor Xa anticoagulant fondaparinux and related compounds. Protected pentasaccharide intermediates and efficient and scalable processes for the industrial scale production of fondaparinux sodium by conversion of the protected pentasaccharide intermediates via a sequence of deprotection and sulfonation reactions are provided.

Synthesis of a polysulfated heparin degradation product

Two suitable methods for the synthesis of the heparin degradation product 2,5-anyhydro-3-O-(α-L-ido-pyranosyluronate)-D-mannitol hexa O-sulfate are reported. The synthesis pathways start from D-glucose and D-glucosamine.

New accesses to L-iduronyl synthons

(PhS)3CLi adds with a total L-ido selectivity onto 3-O-benzyl-1,2-O- isopropylidene-α-D-xylo-dialdose 2, opening the way to the most efficient preparation of 1,2,4-tri-O-acetyl-3-O-benzyl-L-iduronyl synthon 8. Alternatively, in view of combinat